mPCR-guided antimicrobial stewardship in cancer patients with suspected respiratory infections (upper and lower RTIs)
Friday, 12 July 2024
07:30 AM India
10:00 AM Singapore / Hong Kong / Taipei
11:00 AM Tokyo / Seoul
01:00 PM Sydney
Supported by bioMérieux
Post-webinar video is available until 31 October. (APSR members only)
OUTLINE
Diagnosing respiratory infections, particularly pneumonia, in cancer patients presents several challenges due to the unique characteristics and complications associated with cancer and its treatment, especially those undergoing chemotherapy or radiation therapy.
Key clinical challenges complicating the diagnostic process include:
• Symptoms overlap with those of cancer itself or the side effects of cancer treatments
• Atypical presentations or more subtle signs of pneumonia
• Radiographic challenges
• Multifactorial etiologies
These challenges necessitate a comprehensive and multidisciplinary approach to accurately diagnose and manage pneumonia in cancer patients.
Recent implementations of rapid multiplex PCR testing (respiratory panel and pneumonia panel) have significantly advanced the differential diagnosis of respiratory infections. In this webinar, the distinguished speakers will present the utilities of the new molecular diagnostic tool in aiding the diagnosis of respiratory infections in cancer patients, and the pragmatic solutions to overcome certain limitations.
FORMAT
-
Opening Remarks (5 mins)
-
"The Antimicrobial Resistance in Cancer Patients with CAP and HAP and The Roles of Pneumonia Panel" by Dr Rajesh Venkat (15 mins)
-
"The mPCR-guided Antimicrobial Stewardship for Cancer Patients with Respiratory Infections and De-escalation Strategy (Respiratory Panel and Pneumonia Panel)" by Prof Edward Septimus (30 mins)
-
Q&A (10 mins)
-
Closing Remarks (1 min)
SPEAKERS, CHAIR, OPENING/CLOSING REMARKS
Dr Rajesh Venkat
Head of Department, Pulmonary Medicine, Rajagiri Hospital, India
SPEAKER
Prof Edward Septimus
Professor of Internal Medicine, Texas A&M University. Senior Lecturer, Department of Population Medicine, Harvard University.
SPEAKER
Dr Chieh-Liang Wu
Head of Respiratory Infections (non-tuberculous) Assembly
APSR
CHAIR,
OPENING REMARKS
Dr Laksmi Sita Andarini
Head of Lung Cancer Assembly
ASPR